# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-103752
Filing Date
2025-04-29
Accepted
2025-04-29 16:02:34
Documents
32
Period of Report
2025-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d865351ddef14a.htm iXBRL | DEF 14A | 921171
3 | GRAPHIC | g865351dsp1.jpg | GRAPHIC | 13878
4 | GRAPHIC | g865351dsp1a.jpg | GRAPHIC | 88328
5 | GRAPHIC | g865351dsp1b.jpg | GRAPHIC | 3830
6 | GRAPHIC | g865351dsp1c.jpg | GRAPHIC | 3107
7 | GRAPHIC | g865351dsp1d.jpg | GRAPHIC | 3379
8 | GRAPHIC | g865351dsp1e.jpg | GRAPHIC | 3882
9 | GRAPHIC | g865351dsp1f.jpg | GRAPHIC | 17624
10 | GRAPHIC | g865351dsp2a.jpg | GRAPHIC | 1041
11 | GRAPHIC | g865351g02r02.jpg | GRAPHIC | 25795
12 | GRAPHIC | g865351g11l88.jpg | GRAPHIC | 43792
13 | GRAPHIC | g865351g28s62.jpg | GRAPHIC | 77914
14 | GRAPHIC | g865351g29a85.jpg | GRAPHIC | 55384
15 | GRAPHIC | g865351g29b26.jpg | GRAPHIC | 57457
16 | GRAPHIC | g865351g48b65.jpg | GRAPHIC | 72593
17 | GRAPHIC | g865351g48c78.jpg | GRAPHIC | 73042
18 | GRAPHIC | g865351g48d99.jpg | GRAPHIC | 71633
19 | GRAPHIC | g865351g55p32.jpg | GRAPHIC | 28490
20 | GRAPHIC | g865351g61a02.jpg | GRAPHIC | 42855
21 | GRAPHIC | g865351g68c74.jpg | GRAPHIC | 54550
22 | GRAPHIC | g865351sp2.jpg | GRAPHIC | 898
| Complete submission text file | 0001193125-25-103752.txt |  | 3511355

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | adpt-20241231.xsd | EX-101.SCH | 2478
34 | EXTRACTED XBRL INSTANCE DOCUMENT | d865351ddef14a_htm.xml | XML | 268926

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38957 | Film No.: 25887009
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)